| COUNTRY | IMPORTS 2024 | SHARE | 5Y/YR |
|---|---|---|---|
| United States | $76.0B | 22.4% | +7.1% |
| Netherlands | $27.8B | 8.2% | +8.0% |
| Germany | $24.8B | 7.3% | +3.9% |
| China | $19.3B | 5.7% | +1.4% |
| France | $14.0B | 4.1% | +4.3% |
| Japan | $12.4B | 3.7% | -1.1% |
| United Kingdom | $11.0B | 3.3% | +3.6% |
| Belgium | $10.0B | 3.0% | +3.6% |
| Italy | $8.65B | 2.6% | +4.3% |
| Mexico | $8.13B | 2.4% | +10.4% |
| Canada | $7.84B | 2.3% | +5.9% |
| Spain | $6.96B | 2.1% | +6.9% |
| Switzerland | $6.07B | 1.8% | +3.8% |
| Australia | $6.02B | 1.8% | +4.2% |
| South Korea | $5.18B | 1.5% | +3.0% |
| COMPANY | HQ | ANN. |
|---|---|---|
| Nemera | France | 2 |
| Accu-Mold | United States | 1 |
| Averra Packaging | United States | 1 |
| Ingersoll Rand | Ireland | 1 |
| Mavidon | United States | 1 |
| Nelipak Corporation | United States | 1 |
| Olympus Vietnam | Japan | 1 |
| SCG Packaging | Thailand | 1 |
| SÜDPACK Medica | Germany | 1 |
| Trelleborg | Sweden | 1 |
Accu-Mold LLC plans to construct a 53,000-square-foot addition to its Ankeny plant to increase production of precision micro injection molded components. The $33.25 million investment is expected to create 150 jobs, supported by $1.08 million in state tax credits.
Nemera inaugurated Hall 3, a 7,200 sqm production building at its Ponts-et-Marais site in Normandy, France. It adds capacity for the SP9 pump and enables consolidation of SP2 production at Le Tréport, creating up to 100 jobs.
SÜDPACK Medica officially opened its significantly expanded plant in Coulmer, France, on 17 July 2026. The site's clean-room production areas were almost doubled to make primary packaging for pharmaceuticals and medical devices.
Mavidon, a medical device and contract packaging manufacturer, is investing $6 million to expand at the historic Oriole Mill property in Henderson County, North Carolina. The project will create 28 new jobs.
EnSilica was awarded a fully funded three-month feasibility study by a U.S. healthcare technology company to develop a wireless biosensing and therapeutic controller ASIC, valued at about US$200,000.
Nelipak completed its acquisition of Merrill's Packaging, which makes custom thermoformed packaging for medical device, pharmaceutical and life science applications. The deal was reported on December 8, 2025.
Averra Packaging doubled the clean room square footage at its thermoforming facility in Salt Lake City to add an inline medical thermoforming machine.
Nemera has started building a new 3,000 m² production plant at Ponts-et-Marais in Seine-Maritime, with injection presses and assembly lines. The site is expected to employ 100 people by 2027, with delivery planned for April 2026.
Olympus Vietnam, a medical products manufacturer, will invest an additional $53 million in Dong Nai province, Vietnam, raising its total investment to $163 million.
SCG Packaging (SCGP) completed the acquisition of a 90% stake in VEM Thailand, a polymer injection molding maker in Rayong, through its Singapore subsidiary for up to Bt146.2 million (US$4m). The deal was announced on 1 July 2024.
Ingersoll Rand agreed to acquire ILC Dover from New Mountain Capital for an upfront cash price of about $2.325 billion plus an earnout. ILC makes single-use solutions and components for biopharma and medical devices.
Trelleborg Sealing Solutions has signed an agreement to acquire Baron Group, an Australian-Chinese maker of precision silicone components, to strengthen its healthcare and medical offering. Baron had 2023 sales of about SEK 1,000 million and operates two plants in Australia and two in China.
Fresenius Kabi has signed a multiyear supply and service agreement under which Mayo Clinic is expected to buy 10,000 Ivenix large-volume infusion pumps for its hospitals in Minnesota, Arizona and Florida.
Nephron Pharmaceuticals committed to minimum orders of over $400 million over 10 years from Sharps Technology, starting with about $30 million of revenue in the first year, with product delivery scheduled for Q1 2024.
Sharps Technology signed an asset purchase agreement to acquire Nephron Pharmaceuticals' InjectEZ specialty syringe manufacturing facility for $50 million, backed by a term sheet for up to $75 million in debt financing.
Ypsomed held the groundbreaking for a new production facility in the Changzhou National Hi-tech District on 25 April 2023, investing over CHF 35 million in a first phase. Production is expected to start in the second half of 2024.
Fresenius Kabi's Ivenix infusion system has been awarded a Vizient Innovative Technology contract, setting terms for Vizient's U.S. hospital members to evaluate and purchase it. The announcement was made in April 2023.
NEXGEL acquired a 50% interest in CG Converting and Packaging, LLC, a newly formed joint venture with C.G. Laboratories that takes over CG Labs' converting and packaging division. The agreement is effective March 1, 2023.
HMC Premedical SPA has acquired 100% of Dimar SPA, a maker of non-invasive respiratory ventilation medical devices, in Mirandola, Italy. Dimar's founder Maurizio Borsari becomes a direct shareholder of HMC Premedical.
Lianying Medical, parent of the MDKMed brand, has completed the full acquisition of Zhejiang Smith Medical Instruments and the Graseby infusion pump brand from U.S. company ICU Medical. The announcement was made on 10 January 2023; no deal value is stated.
OKAY Industries built a 62,000-square-foot manufacturing facility in the Evolution Free Zone in Grecia, Costa Rica, to relocate and expand its operations, expected to be completed in summer 2024 and adding over 200 jobs.
Waterford, Ireland-based Schivo acquired APN Global and its subsidiary APN Inc., a Quebec maker of AFP valves, fittings and tubing for analytical instruments and minimally invasive surgical devices. The Quebec site will become Schivo's manufacturing centre of excellence.
ADNOC joint venture Borouge signed a memorandum of understanding with Abu Dhabi Medical Devices Company (ADMD) to supply polyolefin materials for medical devices and pharma packaging in Abu Dhabi.
Johnson & Johnson agreed to acquire heart-support device maker Abiomed through a tender offer at $380 per share in cash plus a contingent value right of up to $35 per share, an enterprise value of about $16.6 billion.
PCI Pharma Services has announced a significant expansion of its Tredegar, Wales site, adding two new facilities for solid oral-dose manufacturing and packaging of highly potent drugs. The article gives no investment value or jobs figure.